tyrphostin ag 1024 has been researched along with Neoplasms, Pleural in 1 studies
tyrphostin AG 1024: modulates radiosensitivity in human breast cancer cells; also an IGF1 receptor inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kai, K | 1 |
| D'Costa, S | 1 |
| Sills, RC | 1 |
| Kim, Y | 1 |
1 other study available for tyrphostin ag 1024 and Neoplasms, Pleural
| Article | Year |
|---|---|
Inhibition of the insulin-like growth factor 1 receptor pathway enhances the antitumor effect of cisplatin in human malignant mesothelioma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Cell Division; Cell Line, Tumor; Cisplatin; Humans; Mesothelioma; | 2009 |